Valuation : Camurus AB

Market Cap 35.71B 3.74B 3.22B 3.02B 2.76B 5.15B 353B 5.2B 13.91B 181B 14.04B 13.73B 582B P/E 2026 *
37.3x
P/E 2027 * 24.2x
Enterprise Value 31.19B 3.27B 2.81B 2.64B 2.41B 4.5B 309B 4.54B 12.15B 158B 12.26B 11.99B 508B EV / Sales 2026 *
10.9x
EV / Sales 2027 * 7.98x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.67%
1 week-1.00%
Current month+1.89%
1 month-1.16%
3 months+10.71%
6 months+22.98%
Current year-3.49%
1 week 571.5
Extreme 571.5
608.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 282
Extreme 282
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2002
Director of Finance/CFO 57 30/06/2025
Chief Tech/Sci/R&D Officer 58 31/12/2024
Director TitleAgeSince
Director/Board Member 63 31/12/2001
Chairman 77 31/12/2014
Director/Board Member 61 06/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-1.00%-17.83%+100.71% 3.74B
-0.04%-1.40%+57.16%+108.15% 1,034B
+1.17%+4.76%+56.42%+73.50% 671B
-0.58%+0.80%+22.82%+75.58% 460B
-0.43%-1.00%+28.80%+37.82% 353B
-1.05%+4.91%+24.92%+45.82% 309B
+0.25%+1.70%-0.11%+13.88% 255B
+0.29%+1.63%+56.46%+73.00% 240B
-0.64%+1.39%-16.89%-54.29% 207B
+1.08%+1.59%+33.83%+97.29% 188B
Average -0.11%+1.11%+24.56%+57.15% 372.05B
Weighted average by Cap. -0.09%+1.04%+38.06%+67.68%

Financials

2026 *2027 *
Net sales 2.86B 299M 257M 241M 221M 412M 28.27B 416M 1.11B 14.45B 1.12B 1.1B 46.53B 3.75B 392M 338M 317M 290M 541M 37.09B 545M 1.46B 18.96B 1.47B 1.44B 61.05B
Net income 949M 99.36M 85.49M 80.23M 73.4M 137M 9.39B 138M 370M 4.8B 373M 365M 15.46B 1.45B 152M 131M 123M 112M 210M 14.37B 211M 566M 7.35B 571M 559M 23.66B
Net Debt -4.52B -473M -407M -382M -349M -652M -44.71B -657M -1.76B -22.85B -1.78B -1.74B -73.58B -5.81B -608M -523M -491M -449M -838M -57.47B -845M -2.26B -29.37B -2.28B -2.23B -94.59B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
04/09/26 SEK 596.00 -0.67% 10,214
03/09/26 SEK 600.00 +1.01% 51,590
02/09/26 SEK 594.00 +0.59% 66,895
01/09/26 SEK 590.50 +1.20% 71,430
31/08/26 SEK 583.50 -2.83% 184,554
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
600.00SEK
Average target price
793.00SEK
Spread / Average Target
+32.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock